BACKGROUND: This retrospective study evaluates the degree and distribution of hepatic steatosis in predominantly African-American patients who had liver biopsies over a period of five years in our institution. METHOD: A search in the pathology registry of Howard University Hospital was performed for the presence of fat in liver biopsies. Each biopsy was assessed. RESULTS: Of the 320 liver biopsies that were reviewed, 61 were found to have steatosis. Fifty-six of the 61 patients were African-American. The mean body mass index in those African-American patients was found to be 30. Grade-1 steatosis was found in 16 patients, grade 2 in 22 patients, grade 3 in 14 patients and nine patients had grade-4 steatosis. Four patients fulfilled the criteria for the diagnosis of nonalcoholic fatty liver disease (NAFLD). All four patients had simple steatosis without any inflammation. The frequency of NAFLD in our study population was found to be <2%. Nonalcoholic steatohepatitis was not found in any of our study population. Dyslipidemia was found in all four patients with steatosis. CONCLUSION: NAFLD has a low prevalence in African-American patients. Nonalcoholic steatohepatitis was not found in any of the African-American patients seen at our institution.
BACKGROUND: This retrospective study evaluates the degree and distribution of hepatic steatosis in predominantly African-American patients who had liver biopsies over a period of five years in our institution. METHOD: A search in the pathology registry of Howard University Hospital was performed for the presence of fat in liver biopsies. Each biopsy was assessed. RESULTS: Of the 320 liver biopsies that were reviewed, 61 were found to have steatosis. Fifty-six of the 61 patients were African-American. The mean body mass index in those African-American patients was found to be 30. Grade-1 steatosis was found in 16 patients, grade 2 in 22 patients, grade 3 in 14 patients and nine patients had grade-4 steatosis. Four patients fulfilled the criteria for the diagnosis of nonalcoholic fatty liver disease (NAFLD). All four patients had simple steatosis without any inflammation. The frequency of NAFLD in our study population was found to be <2%. Nonalcoholic steatohepatitis was not found in any of our study population. Dyslipidemia was found in all four patients with steatosis. CONCLUSION: NAFLD has a low prevalence in African-American patients. Nonalcoholic steatohepatitis was not found in any of the African-American patients seen at our institution.
Authors: L Rubbia-Brandt; R Quadri; K Abid; E Giostra; P J Malé; G Mentha; L Spahr; J P Zarski; B Borisch; A Hadengue; F Negro Journal: J Hepatol Date: 2000-07 Impact factor: 25.083
Authors: L F Hourigan; G A Macdonald; D Purdie; V H Whitehall; C Shorthouse; A Clouston; E E Powell Journal: Hepatology Date: 1999-04 Impact factor: 17.425
Authors: Jeffrey D Browning; Lidia S Szczepaniak; Robert Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs Journal: Hepatology Date: 2004-12 Impact factor: 17.425
Authors: Stephen H Caldwell; Danielle M Harris; James T Patrie; Elizabeth E Hespenheide Journal: Am J Gastroenterol Date: 2002-06 Impact factor: 10.864
Authors: Sahil Mittal; Yvonne H Sada; Hashem B El-Serag; Fasiha Kanwal; Zhigang Duan; Sarah Temple; Sarah B May; Jennifer R Kramer; Peter A Richardson; Jessica A Davila Journal: Clin Gastroenterol Hepatol Date: 2014-08-19 Impact factor: 11.382
Authors: James C Barton; Luigi F Bertoli; Thomas J Alford; J Clayborn Barton; Corwin Q Edwards Journal: Am J Med Sci Date: 2015-01 Impact factor: 2.378
Authors: Deborah Edelman; Harmit Kalia; Maria Delio; Mustafa Alani; Karthik Krishnamurthy; Mortadha Abd; Adam Auton; Tao Wang; Allan W Wolkoff; Bernice E Morrow Journal: Mol Genet Genomic Med Date: 2015-08-11 Impact factor: 2.183